China Biotech Services Holdings Limited (HKG:8037)

Hong Kong · Delayed Price · Currency is HKD

0.7000

-0.0400 (-5.41%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Others	141.00K	3.74M	13.52M	7.96M	1.30M
Others Growth	-96.23%	-72.34%	69.95%	512.00%	-22.99%
Medical and Health Related Services	39.61M	193.07M	1.62B	607.78M	646.75M
Medical and Health Related Services Growth	-79.48%	-88.10%	166.94%	-6.03%	1107.72%
Insurance Brokerage	30.60M	18.16M	6.93M	7.92M	6.88M
Insurance Brokerage Growth	68.47%	161.98%	-12.48%	15.23%	186.22%
Pharmaceutical Products	1.22M	2.57M	281.21M	107.00K	869.00K
Pharmaceutical Products Growth	-52.66%	-99.09%	262714.02%	-87.69%	-39.99%
Intersegment Revenue	-1.06M	-5.57M	-72.54M	-	-
Total	70.51M	211.99M	1.85B	623.76M	655.79M
Total Growth	-66.74%	-88.55%	196.83%	-4.88%	1007.49%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Hong Kong	70.51M	211.97M	1.85B	623.76M	655.79M
Hong Kong Growth	-66.74%	-88.55%	196.80%	-4.88%	1009.84%
PRC except Hong Kong	2.00K	13.00K	201.00K	-	-
PRC except Hong Kong Growth	-84.62%	-93.53%	-	-	-
Total	70.51M	211.99M	1.85B	623.76M	655.79M
Total Growth	-66.74%	-88.55%	196.83%	-4.88%	1007.49%

Source: S&P Global Market Intelligence.